Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt

Background. The introduction of MenAfriVac in campaigns targeting people aged 1–29 years across the African meningitis belt has successfully reduced meningitis incidence and carriage due to Neisseria meningitidis group A (MenA). It is important to consider how best to sustain population protection i...

Descripción completa

Detalles Bibliográficos
Autores principales: Karachaliou, Andromachi, Conlan, Andrew J. K., Preziosi, Marie-Pierre, Trotter, Caroline L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639487/
https://www.ncbi.nlm.nih.gov/pubmed/26553693
http://dx.doi.org/10.1093/cid/civ508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639487/
https://www.ncbi.nlm.nih.gov/pubmed/26553693
http://dx.doi.org/10.1093/cid/civ508

Ejemplares similares